PharmacyOncologyPharmaceuticsChemotherapyDrug DeliveryNanoparticle Drug DeliveryCancer Drug DeliveryCancer NanomedicineLiposomal FormulationsLiposome-based DeliveryNanomedicineNanoparticle CharacterizationCytotoxicity AssaysLiposomal NanocarriersLiposome Delivery SystemsLiposome Drug DeliveryLiposomesNanoparticle CytotoxicityPegylated LiposomesThermosensitive Liposomes
cytotoxicity of GEM-TSLnps + mHT treated pancreatic cancer cell lines was significantly higher than GEM treated. The IC50 values for PANC-1, MiaPaCa-2 and BxPC-3 cells GEM-TSLnps + mHT treated were 1.2 to 3.5 fold-higher than GEM treated. Among the cell lines, GEM-TSLnps + mHT treated PANC-1 and MiaPaCa-2 cells show significantly reduced reproductive viability compared with the GEM treated cells. Flow cytometric and confocal images revealed high Rho-TSLnps cellular uptake. Our findings suggest that GEMTSLnps+ mHT can significantly enhance cytotoxic effect of GEM and could serve as a new chemotherapy modality for delivering GEM.
24
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2015 · 11.9K citations · Full text
Clonogenic assay of cells in vitro
Nicolaas A.P. Franken, Hans M. Rodermond, Jan Stap et al. · Nature Protocols · 2006 · 4.2K citations
Malcolm J. Moore, David Goldstein, John Hamm et al. · Journal of Clinical Oncology · 2007 · 3.9K citations
Medicine, Oncology, Pharmacology +17